Caught Off Guard

SARS reveals gaps in global disease defense















Share on Tumblr

WORLDWIDE SPECTER of SARS

WORLDWIDE SPECTER of SARS leads flight attendants from Qatar Airways to don masks on arrival at Jakarta, Indonesia. Image: SUPRI Reuters

"The hospitals have been closed and people are dying." A brief but chilling dispatch from the city of Guangzhou provided one of the outside world's first hints of the chaos in southern China's Guangdong Province as the mysterious disease now known as SARS spread unchecked. "When I got [the message], the province was already in disarray, with wholesale demonstrations in the streets," says retired U.S. Navy infectious disease investigator Stephen Cunnion, of his friend's report that he posted to ProMED-mail, an international infectious disease listserv.

Chinese officials have issued an extraordinary apology, effectively admitting that months of secrecy and denial after the new illness appeared last November created a case study in how not to handle an infectious disease outbreak. But in the end, China might have done the world a favor of sorts by providing a test of global readiness for an even more devastating future epidemic, whether naturally occurring or unleashed in an act of terrorism. With SARS (severe acute respiratory syndrome) having hit 22 countries by mid-April, world preparedness looks decidedly mixed.

"This was not the big one," says David Heymann, executive director for communicable diseases for the World Health Organization. His global alerts helped most countries to gird for SARS. But Heymann, whose group keeps a lookout for killer influenza strains that might emerge from the same region, admits that he is worried."We've always had confidence in Hong Kong," with its more modern and better-financed facilities, Heymann states, "whereas we didn't have confidence that China was prepared. Now I think we'll have to reassess Hong Kong."

The spread of SARS may have been no surprise to the Institute of Medicine (IOM), which in March quietly released a report, "Microbial Threats to Health: Emergence, Detection, and Response," an update to its startling 1992 analysis of gaping holes in U.S. defenses against a natural microbial assault. The IOM's latest analysis takes a global view and adds the risk of bioterrorism. Although the new study finds a few areas of improvement, it concludes that "the outlook is bleak on a number of fronts."

The report notes that global surveillance has improved--certainly none of the electronic systems that alerted the world to SARS existed in 1992--but experts judge it inadequate. Stephen Morse of Columbia University, an author of the original IOM report, believes that health surveillance is not comprehensive enough. "There's still a lot of frag- mentation of knowledge. Nature isn't standing still; neither are potential terrorists." For instance, even with its knowledge of the severe pneumonia outbreak in Guangdong as early as February 9, WHO could do nothing without Chinese cooperation. "What we never have is the teeth to go in if a country refuses information," Heymann laments. A full month passed until WHO learned about pneumonia patients who had infected an unusually high number of hospital staff in Hanoi, Hong Kong and Singapore. By then it was too late for Hong Kong, where authorities were caught off guard by the ability of SARS to spread not only through close contact but also through contaminated surfaces and possibly sewage. With dozens of new cases daily--many of them hospital workers--city health officials admitted defeat in containment efforts by early April.

Preventing such a meltdown in medical infrastructure is the rationale behind the current U.S. program to vaccinate health workers against smallpox. But there are no vaccines against some of the other "Category A" bioagents, considered the most dangerous potential weapons, such as the plague, tularemia and Ebola pathogens. And no vaccine or drug is effective against the suspected SARS agent, a coronavirus so different from others in that diverse viral family, it earned its own group designation.

SARS is unlikely to have been a product of bioengineering. Terrorists today are more apt to use known pathogens than to invent one, Morse says, but "a few years down the road, those who are technically sophisticated will be able to do things that are more imaginative."



Comments

Add Comment
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

  • docfreeride This season of Mad Men, I'm actively rooting for someone to kill Don Draper. Too much collateral damage if we wait for his redemption.
    3 minutes ago · reply · retweet · favorite
  • mdichristina @MRAKdesign Looks like rain for today--presume you sent it here?!
    7 minutes ago · reply · retweet · favorite
  • huler Trying, failing to spend money on Delta Airlines. Unnavigable website. 2+ hours hold time. But -- they promise to call me when it's my turn.
    50 minutes ago · reply · retweet · favorite
More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital

Latest from SA Blog Network

  SA Digital

Email this Article

Caught Off Guard

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X